refused consent for the use of their data in the following analysis. Thirty-two of the patients were 13 receiving 2 mg/day nitisinone treatment (13 of them started treatment within 3 days of testing) which 14 is expected to slow progression of the disease, but not to reverse the effects. Eighteen of the patients 15 had had one or more joints replaced. fitted to the patient data and showed no significant variation with age. An appropriate sigmoid curve 2 was fitted to the data ("R P", 2014) using starting and ending values from the regressions at the end 3 of (a) and at the start of (b) respectively. The fitted curve showed a discontinuity with its 50% point 4 around age 37, providing support for the conjecture suggested by the median filtering. Adjusting the 5 start and end of the respective regressions to 37 years and making minor adjustments to the start and 6 end values of the sigmoid curve from the revised regressions produced an almost identical sigmoid 7 curve (Figure 2) which was used to model the change of gait deviation as a function of age in our AKU 8 sample. Only patients above 47 years had joint replacements (red empty and filled triangles in Figure 1 ) and 1 their gait deviation was greater (2.70±0.47, N=14) than that of patients without joint replacements 2 (2.24±0.4, N=25, red empty and filled circles in Figure 1 ). There are 8 AKU patients in the age range 3 37-47 years without joint replacements but considerable deviations from normal gait. Adults older than 37 years of age with AKU show more deviation from normal gait than the younger 27 group. Nevertheless if our method based on the MDPmean was used to decide if a patient moved away 28 from normality, then the sensitivity/specificity would likely be low with false positives given that 23% 29 of AKU patients fall within the 95% confidence interval of the control group. Further evaluation of the 30
MDPmean as a method to separate a patient with AKU from controls is necessary using a larger sample. 31 decisions of when a joint replacement is indicated. Gait does not easily return to normality; in 1 osteoarthritis, gait was shown not to return to normal until about 11 months after total hip 2 arthroplasty (Beaulieu et al. 2010). Potential mechanisms underlying slow recovery are: unnecessary 3 but continued pain avoidance strategies and persistent muscle weakness due to disuse, both of which 4 may hinder not only the affected but the contralateral side too. Persisting gait abnormality following 5 joint replacement in AKU is likely to be due to the systemic nature of the disease which affects 6 anatomical structures beyond the joint itself. AKU potentially affects all joints including their related 7 ligaments, tendons and muscles and this might explain why repairing a single joint may not lead to a 8 rapid recovery. older individuals with AKU is referenced to a rather coherent definition of gait normality regardless of 22 age. Increased gait deviations therefore were due to genuine deterioration of gait related to AKU 23 together with other factors like joint replacements and nitisinone treatment. More in-depth sub-24 group analyses will be required to differentiate between these factors. 25 26 A limitation of our method is that on its own the single number MDPmean can only be used to flag an 27 increased deviation of gait from normality. This should then be followed up by establishing the specific 28 gait problems which eventually is expected to lead to improved clinical decision making and treatment. 29
Movement of body-attached markers was used to quantify deviation of gait but this approach can be 30 complemented by including the forces acting on the body at each joint. Such an extension of the 31 method may offer further advantages due to its focus on joint loading which is the ultimate cause of 32 pain in alkaptonuria. An inevitable limitation of our study was the low number of participants and the 33 cross-sectional nature of gait data.
